A group consisting of Battelle, AmplifyBio and Andelyn Biosciences has received a seat on an eight-year, $149 million indefinite supply, indefinite amount (IDIQ) contract automobile for the Nationwide Institute of Neurological Issues and Stroke within the U.S.

As one of many prime contractors on the multi-award IDIQ, the group will present manufacturing and nonclinical assist for translational improvement of therapeutic biotechnology merchandise within the Nationwide Institutes of Well being’s drug discovery and improvement program that addresses neurological situations. 

“The contract will likely be used to advance modern therapies, together with cell and gene remedy, for a broad number of neurological ailments,” stated Drew Cawthon, enterprise line director of Battelle’s life science analysis. 

“We’ll be researching new and novel methods to deal with uncommon ailments, ones that don’t but have efficient remedies.” 

Accelerating therapies

“The success of this proposal bid permits AmplifyBio to reveal our continued partnership with Battelle and formalizes a brand new partnership with Andelyn Biosciences,” stated Jerry Hacker, EVP and chief business officer, AmplifyBio. 

“We sit up for bringing our experience in superior remedy analytics and preclinical examine capabilities to speed up groundbreaking therapies for neurological situations.” 

Eric Blair, chief business officer at Andelyn, added: “We’re proud to be supporting this analysis program by NINDS. At Andelyn, we’re wholly dedicated to creating an influence with regards to manufacturing therapies, notably with regards to treating uncommon illness. We’re wanting ahead to working alongside our companions and offering hope to the sufferers impacted.”

Battelle provides assay assist and integration companies to assist regulatory approval, in addition to a long time of federal authorities contracting expertise that helps its place because the prime contractor. 

All three of the groups actively collaborated on the profitable proposal. As they bid on job orders, they count on for every associate to obtain comparable shares of the work, counting on the differentiated strengths of every group to satisfy the shopper’s wants. 

About Battelle

At know-how facilities and nationwide laboratories world wide, Battelle conducts analysis and improvement, designs and manufactures merchandise, and delivers important companies for presidency and business prospects. Headquartered in Columbus, Ohio, since its founding in 1929, Battelle serves the nationwide safety, well being and life sciences, and power and environmental industries. 

About Andelyn Biosciences, Inc.

Andelyn is a biopharmaceutical CDMO within the higher Columbus, Ohio, space. Its capabilities span viral vector course of and analytical improvement, small to large-scale adherent and suspension-based GMP drug substance manufacturing as much as 2000L, and drug product manufacturing companies. 

About AmplifyBio

AmplifyBio is a preclinical CRO targeted on toxicology, security, and pharmacology testing to advance therapeutics. It was spun out of Battelle in Could of 2021. 

Source link